Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mesotheliomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03075527
What this trial is testing

Durvalumab in Combination With Tremelimumab in Malignant Pleural Mesothelioma

Who this might be right for
Mesothelioma
Dana-Farber Cancer Institute 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT06318286
What this trial is testing

Study of Pembrolizumab Plus Chemotherapy With Lenvatinib for Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Hyogo Medical University 25
Very early researchUnknownNCT04489862
What this trial is testing

ΑPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors

Who this might be right for
Non-small-cell Lung CancerMesothelioma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 10
Early research (Phase 1)Study completedNCT02071862
What this trial is testing

Study of the Glutaminase Inhibitor CB-839 in Solid Tumors

Who this might be right for
Solid TumorsTriple-Negative Breast CancerNon Small Cell Lung Cancer+7 more
Calithera Biosciences, Inc 210
Early research (Phase 1)Study completedNCT00535951
What this trial is testing

Pharmacokinetic, Safety, and Efficacy Effects of Oral LBH589 on Dextromethorphan in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer or Malignant Pleural Mesothelioma

Who this might be right for
Carcinoma, Non-Small-Cell LungMesothelioma
Novartis Pharmaceuticals 18
Not applicableStudy completedNCT02300883
What this trial is testing

Observational Prospective Analysis of Biological Characteristics of Mesothelioma Patients

Who this might be right for
Malignant Mesothelioma
Armando Santoro, MD 100
Testing effectiveness (Phase 2)Ended earlyNCT03717415
What this trial is testing

Rebastinib (DCC-2036) in Combination With Carboplatin in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumor
Deciphera Pharmaceuticals, LLC 70
Early research (Phase 1)Study completedNCT00703638
What this trial is testing

Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+5 more
Masonic Cancer Center, University of Minnesota 16
Not applicableStudy completedNCT02603315
What this trial is testing

Vascularity Impact on the Treatment Outcome in Malignant Pleural Mesothelioma(VITMPM)

Who this might be right for
Malignant Pleural Mesotheliomas
Ain Shams University 50
Early research (Phase 1)Active Not RecruitingNCT03212404
What this trial is testing

Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers

Who this might be right for
Lung NeoplasmsCarcinoma, Non-Small-Cell LungCarcinoma, Small Cell+10 more
Checkpoint Therapeutics, Inc. 272
Testing effectiveness (Phase 2)Study completedNCT00316225
What this trial is testing

Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen

Who this might be right for
Non-small Cell Lung CancerMesotheliomaLung Neoplasms
Eli Lilly and Company 31
Early research (Phase 1)Ended earlyNCT03608618
What this trial is testing

Intraperitoneal MCY-M11 (Mesothelin-targeting CAR) for Treatment of Advanced Ovarian Cancer and Peritoneal Mesothelioma

Who this might be right for
Peritoneal MesotheliomaFallopian Tube AdenocarcinomaAdenocarcinoma of the Ovary+1 more
MaxCyte, Inc. 14
Early research (Phase 1)Looking for participantsNCT06885697
What this trial is testing

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

Who this might be right for
MesotheliomaNeoplasmsStomach Neoplasms+5 more
National Cancer Institute (NCI) 100
Testing effectiveness (Phase 2)UnknownNCT05598268
What this trial is testing

T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors.

Who this might be right for
Advanced Solid TumorLung CancerLiver Cancer+2 more
ImmVira Pharma Co. Ltd 74
Testing effectiveness (Phase 2)Study completedNCT03654833
What this trial is testing

Mesothelioma Stratified Therapy (MiST) : A Multi-drug Phase II Trial in Malignant Mesothelioma

Who this might be right for
Mesothelioma, Malignant
University of Leicester 186
Testing effectiveness (Phase 2)UnknownNCT00454519
What this trial is testing

Surgery Plus Intraoperative Peritoneal Hyperthermic Chemotherapy (IPHC) to Treat Peritoneal Carcinomatosis

Who this might be right for
Stomach NeoplasmsColorectal NeoplasmsNeoplasm Metastasis+1 more
Wuhan University 60
Testing effectiveness (Phase 2)Study completedNCT01358084
What this trial is testing

Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced MPM

Who this might be right for
Advanced Malignant Pleural Mesothelioma
AGC Biologics S.p.A. 137
Not applicableStudy completedNCT01776385
What this trial is testing

The ISET (Isolation by Size of Epithelial Tumor Cells) and the CellSearch Methods in Malignant Pleural Mesothelioma

Who this might be right for
Pleural NeoplasmsMesotheliomaPneumothorax+3 more
Centre Hospitalier Universitaire de Nice 9
Large-scale testing (Phase 3)Study completedNCT02899299
What this trial is testing

Study of Nivolumab Combined With Ipilimumab Versus Pemetrexed and Cisplatin or Carboplatin as First Line Therapy in Unresectable Pleural Mesothelioma Patients

Who this might be right for
Mesothelioma
Bristol-Myers Squibb 605
Not applicableUnknownNCT03210298
What this trial is testing

International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)

Who this might be right for
Peritoneum CancerPeritoneum NeoplasmPleural Cancer+12 more
Sabine Rhode 1,000
Next Page